Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
NCT ID: NCT05705011
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
240 participants
OBSERVATIONAL
2019-03-01
2023-03-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* What determines the time to initiate dialysis? Cognitive impairment or frailty?
* What does predict the time to death? Presence of frailty or cognitive impairment?
* What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frailty Assessment Among Kidney Transplant Candidates
NCT04811417
Chronic Kidney Disease Among Frail Elderly
NCT02351349
Exploring Predictors of Quality of Life in Older Adults With End-Stage Kidney Disease Receiving In-Center Hemodialysis
NCT07129083
Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5
NCT06825234
Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2
NCT05125913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2 separated by more than 3 months.
Exclusion Criteria
* Chronic kidney disease stages 1,2, and 3.
* Dialysis dependence
* History of kidney transplantation.
* Initial visit with the health care provider.
* Recent acute kidney injury.
* Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)
* Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment
* Patients who are blind or with limb amputation.
* Patients who refuse to participate.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grigore T. Popa University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hani Hussien
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hani Hussien, MD
Role: PRINCIPAL_INVESTIGATOR
University of Medicine and Pharmacy "Grigore T. Popa" - Iași
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Medicine and Pharmacy "Grigore T. Popa"
Iași, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nephrogeriatrics
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.